Semnur Pharmaceuticals, Inc.
SMNR
$9.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -11,656.09% | 10.00% | 55.84% | -39.80% | |
| Total Depreciation and Amortization | -- | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 92,131.58% | -38.02% | -48.60% | -16.94% | |
| Change in Net Operating Assets | 1,322.58% | 6,652.94% | 120.91% | 116.49% | |
| Cash from Operations | -402.59% | 129.74% | 81.52% | -2.91% | |
| Capital Expenditure | -- | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | -- | |
| Cash from Investing | -- | -- | -- | -- | |
| Total Debt Issued | 84.76% | 44.38% | -43.16% | 878.21% | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -46.11% | -- | -- | -- | |
| Cash from Financing | 412.09% | -124.47% | -81.79% | 3.30% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 1,600.00% | 2,500.00% | -200.00% | 42.86% | |